logo
Buddy Check 3: Jeff Stauffer

Buddy Check 3: Jeff Stauffer

Yahoo04-04-2025

BLUFFTON, S.C. (WSAV) — 1% of men are diagnosed with breast cancer every year.
In April's Buddy Check 3 report, an email to WSAV's Tina Tyus-Shaw from a Bluffton man led to a face to face meeting about being in that 1%.
After 30 years in health care, Jeff Stauffer and his wife Linda retired and decided to make Bluffton their home.
The move was something they had been looking forward to, but not long after they settled into their home he discovered he had breast cancer when he was on the mend from a shoulder injury.
'My arm was in a sling with that little cushion behind it,' said Stauffer. 'When I was finally able to take it off, get in the shower I noticed a lump in my armpit, and I also noticed one right next to my sternum.'
Having a background in health care, he knew all about breast cancer. In addition, his own mother had the disease. What he didn't realize is that he was one of only 1% of men who get it.
'I didn't have any pain because all of the nerves were cut,' Stauffer said. 'I had a total mastectomy. I didn't have to get radiation or the more traditional intravenous chemo, just take hormone therapy tamoxifen. They said you're lucky, you're on a pill for 5 years.'
As he navigates the after effects of his treatment, he continues to take medication to help keep him in remission.
Now, this Air Force Veteran is living a full, happy life.
On this particular day, he reflected on the life of his father, a World War II Veteran.
'Don't ignore any unusual sensations if you just happen to touch your chest or anything,' Stauffer said. 'You're not going to feel it just sitting in the chair. You've got to go in and find it. Even if you go to the doctor and it's a false alarm, better going to the doctor than ignoring something.'
Stauffer says he's most thankful for his treatment at Beaufort Memorial Hospital.
'My primary care Dr. Wallace, and my surgeon Dr. Deanna Mansker up at Beaufort Memorial. They've all been great. Once a year, I have a mammogram. She does the breast exam on the other side to make sure nothing is coming up there.'
Cancer nurse navigators there said that national guidelines indicate that breast cancer usually occurs in men between the ages of 60 and 70 years old and make up less than 1% of all cases of breast cancer.
In addition, they suggest all men should look for lumps that can be felt or discharge from the nipple.
If you have those, visit your doctor to get checked out.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mary Beth Nienhaus Activity Center officially opens, providing social opportunities for adults 50+
Mary Beth Nienhaus Activity Center officially opens, providing social opportunities for adults 50+

Yahoo

time2 hours ago

  • Yahoo

Mary Beth Nienhaus Activity Center officially opens, providing social opportunities for adults 50+

APPLETON, Wis. (WFRV) – After all of the anticipation and excitement, the Mary Beth Nienhaus Activity Center has finally opened, with a celebration event on Friday afternoon. The activity center, formerly known as the , provides adults 50 years and older with plenty of opportunities to socialize, learn and thrive. Green Bay native Tony Shalhoub to host global food docuseries on CNN From wellness studios to high-tech classrooms and gaming areas, the facility features a plethora of ways for adults looking to keep up their activity level to do so. It also features the only indoor pickleball court for adults in Appleton. The center is still holding a fundraiser, looking to raise about $6.5 million, and it is 85% of the way there. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

The monthly tab for her in-home elder care: $18,000. She can cover it, but how many others can?
The monthly tab for her in-home elder care: $18,000. She can cover it, but how many others can?

Los Angeles Times

time11 hours ago

  • Los Angeles Times

The monthly tab for her in-home elder care: $18,000. She can cover it, but how many others can?

Marian Sunabe drives from her home in South Pasadena to visit her 100-year-old mother in Gardena once a week or so, and I tagged along on a recent morning to talk about the crippling cost of elder care. Sunabe, a retired school psychologist, said her mother is independent-minded, loves the comfort of her own home and doesn't want to move in with Sunabe or her brother. For the last four years, Reiko Kobata has had a daytime caregiver. But lately, after taking a fall and getting sick with pneumonia, there are times when a nighttime caregiver has been added. The daytime tab, for a 13½-hour shift, is $320. The 11-hour nighttime shift costs just under $300, bringing the daily total to $620. That adds up to a staggering $18,600 a month. When the night shift caregiver isn't needed, the amount is about half that. 'Most folks would not be able to afford this. But there aren't many options other than admitting them to a board and care facility,' Sunabe had said in an email, and even that can run several thousand dollars a month. 'I've known people who have had to quit their job … to care for their aging parent. It can easily drain all of your savings and assets — not a good system.' In fact, it's a national crisis, and the United States lags behind many developed countries at a time when the global population is rapidly aging. 'Americans are not prepared for the challenges of caregiving,' Paul Irving, a senior advisor at the Milken Institute, says in 'Caregiving,' a new PBS documentary. Families ultimately learn, he says, that essential care is not covered by health insurance, 'so incredibly, more and more middle-class Americans are forced to pay down to poverty so that they can qualify for Medicaid. That's a crazy system for them and for our federal government.' And it might not be an option much longer, given the hatchet job on Medicaid by the Trump administration and Congress. As Sunabe and I drove south, I told her about my friend Morrie Markoff, who lived to 110. He was fortunate to have saved enough for in-home care that cost $14,000 a month. But he and Sunabe's mother are not the norm. I'd also written about 102-year-old World War II vet Paul Hult, who quickly burned through his life savings after taking a fall and needing in-home care. Sunabe had neatly penciled columns of numbers for me on a sheet of lined paper, outlining the math of her mother's care. Kobata was pooling Social Security, income from a rental property she and her late husband owned, pensions, long-term care insurance and retirement savings to cover the monthly $18,600 bill. Kobata pays an agency that provides, and in turn compensates, the caregiver. In such arrangements, agencies take as much as half the total. That can leave something close to minimum wage for the caregiver, making it hard to recruit more of them to an industry with a critical workforce shortage. As a result, many caregivers are undocumented and work off the books. That saves clients money, because there's no split with an agency. And a lot of caregivers get free room and board while on duty, but sacrifice their own privacy and time with family. Women from the Philippines — some with legal status, some without — make up a sizable portion of the workforce in California. As I've reported, some of them share barracks-style housing, and many are living in fear of deportation at the moment thanks to the Trump administration's immigration raids. So what we're witnessing is a colossal public policy failure, and it's not as if the age wave — cresting for decades — could have come as a surprise. The Public Policy Institute of California projects that in 2040, the number of Californians 65 and older will hit 9 million, representing 22% of the population, up from 14% in 2020. By necessity, more and more families will resort to an approach fairly common in immigrant cultures. They'll take care of their own, live together, do a lot of juggling and hope that when the need arises, they won't be bankrupted by medical care. Sunabe exited the 110 Freeway and drove through Gardena streets where she used to walk to school. As we approached the family home, she told me her mother still likes to personally write checks to pay her bills, but doesn't keep track of the total cost of her own care. 'Sometimes she'll ask, 'What is all this money going for?'' Sunabe said. Sunabe parked in the driveway of the house she grew up in. Her parents bought it about 65 years ago for $13,000, when Harold Kobata worked as a chemical engineer and his wife was a teacher's aide and school office assistant. Kobata entered the living room with the aid of a walker, but otherwise appeared to be in miraculously good health and even better spirits. Her grandson, who stays with his grandmother when he works as a sushi chef at a nearby restaurant, was leaving for his shift. Kobata settled onto a comfortable sofa against a wall of family photos. She told me she enjoys a morning walk through the neighborhood and likes to spread out the L.A. Times each day and read the whole paper, front to back. She tends to her garden, plays solitaire on her computer, follows the Dodgers and has a favorite player — Shohei Ohtani. I told Kobata she didn't look 100. 'How do you feel?' I asked. 'I don't know,' she said. 'How are you supposed to feel?' She thought about it and said she feels about 90. We had a lovely visit, going on two hours, but I didn't want to keep Kobata from her nap. On the ride back to South Pasadena, Sunabe said her mother's situation is sustainable for the time being, but she wonders about the broader societal challenge. 'If you've been in a house for a long time, so long that you don't want to move out of it because it's so comfortable and familiar, then you probably have a fortune in equity,' she said. 'And if you were to downsize or move into a more communal setting, you'd solve the isolation problem and the care problem by cashing out that equity.' That's an option for some people, along with unpaid help from relatives or friends, and a state program providing limited care for low-income and elderly residents. But there are no easy or inexpensive solutions, according to Irving and to UCLA professor emeritus Fernando Torres-Gil, who also appears in 'Caregiving' and says that when he's asked for advice on elder care, he has a two-word response: 'You're screwed.' In the middle of the last century, Torres-Gil said, the U.S. invested heavily in institutional care, enabling 'a huge for-profit industry to take hold.' Other countries instead invested in public financing of community-based and home-centered care, including Singapore, Japan, Taiwan and South Korea. 'We are behind the curve,' Irving said. 'We are the only developed country … without a system of universal health care, leading to high rates of chronic disease and shorter health spans and life expectancy … And the system — if you can call it a system — fails our elders. Assisted living communities and nursing homes are unaffordable for most Americans.' The only hope, ironically, may be the age wave itself. As more and more people wipe out, policymakers might discover the cost of ignoring their cries for help.

How Is Hologic's Stock Performance Compared to Other Health Care Equipment Stocks?
How Is Hologic's Stock Performance Compared to Other Health Care Equipment Stocks?

Yahoo

time11 hours ago

  • Yahoo

How Is Hologic's Stock Performance Compared to Other Health Care Equipment Stocks?

With a market cap of $14.3 billion, Hologic, Inc. (HOLX) is a Massachusetts-based medical technology firm, primarily focused on women's health. The company develops, manufactures, and sells a comprehensive suite of solutions, including molecular diagnostics, medical imaging systems, and surgical devices Companies worth $10 billion or more are generally described as 'large-cap stocks,' and Hologic fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the medical instruments & supplies industry. The company benefits from robust innovation, supported by over 7,000 patents, which fuels its proprietary technologies and product differentiation. Its diagnostics segment, particularly in molecular testing, has shown strong growth, positioning Hologic well in the expanding global healthcare market. 2 Outstanding Stocks Under $50 to Buy and Hold Now Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here? A $1 Billion Reason to Buy MicroStrategy Stock Here Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. However, HOLX shares have retreated 24.5% from their 52-week high of $84.67 touched on Aug. 9, 2024. Meanwhile, HOLX stock has surged 3.2% over the past three months, surpassing the SPDR S&P Health Care Equipment ETF's (XHE) 4.8% plunge over the same time frame. HOLX stock has plummeted 11.3% on a YTD basis and 10.5% over the past 52 weeks, compared to XHE's 10.6% dip in 2025 and a 6.3% fall over the past year. The stock has remained consistently below its 200-day moving average since early December last year, but has climbed above its 50-day moving average since late May. On May 27, HOLX shares surged more than 14%, leading S&P 500 gainers, after reports emerged that TPG Inc. (TPG) and Blackstone Inc. (BX) made (and were turned down on) a non-binding ~$16 billion takeover bid, valuing the company at $70–$72 per share. The stock's rally reflected investor optimism and underscored the premium valuation placed on its leadership in women's health and diagnostic capabilities. In the competitive healthcare equipment industry, top rival, Align Technology, Inc.'s (ALGN) 13.7% drop on a YTD basis and 25.7% decline over the past year trails HOLX's losses in the same time frames. Among the 19 analysts covering the HOLX stock, the consensus rating is a 'Moderate Buy.' Its mean price target of $68.27 suggests a 6.7% upside potential from current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store